Clarithromycin: Pharmacokinetic and Pharmacodynamic Interrelationships and Dosage Regimen
- 1 January 1999
- journal article
- review article
- Published by Taylor & Francis in Journal of Chemotherapy
- Vol. 11 (1) , 11-27
- https://doi.org/10.1179/joc.1999.11.1.11
Abstract
In the last decade three important pharmacodynamic parameters: T>MIC, Cmax/MIC and AUC/MIC, have been shown to correlate well with in-vitro antimicrobial efficacy and that found in animal models, differentiating among groups of antibiotics with diverse mechanisms of action such as exposure time or concentration-dependent effect. The macrolide antimicrobial agents display variable concentration-dependent killing, indicating the increasing importance of the Cmax parameter. Clarithromycin, whose T>MIC and AUC influence its clinical efficacy, is in an intermediate position between its progenitor, erythromycin, and the azalides. This paper reviews pharmacokinetic and pharmacodynamic characteristics of clarithromycin, examining the potential impact of these properties on the dose and the optimal interval between administrations.Keywords
This publication has 49 references indexed in Scilit:
- Comparative Study of Pharmacokinetic Parameters Between Clarithromycin and Erythromycin Stearate in Relation to Their Physicochemical PropertiesDrug Development and Industrial Pharmacy, 1998
- Comparative pharmacodynamics of clarithromycin and azithromycin against respiratory pathogensInfection, 1995
- Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporinsDiagnostic Microbiology and Infectious Disease, 1995
- The postantibiotic effect of clarithromycin and its major human metabolite, 14-hydroxyclarithromycinJournal of Antimicrobial Chemotherapy, 1993
- Clarithromycin Clinical PharmacokineticsClinical Pharmacokinetics, 1993
- Single‐ and Multiple‐dose Pharmacokinetics of Clarithromycin, a New Macrolide AntimicrobialThe Journal of Clinical Pharmacology, 1993
- ClarithromycinDrugs, 1993
- Clarithromycin, a unique macrolide: A pharmacokinetic, microbiological, and clinical overviewDiagnostic Microbiology and Infectious Disease, 1992
- Clinical Pharmacokinetic Properties of the Macrolide AntibioticsClinical Pharmacokinetics, 1989
- The development of macrolides and related compoundsJournal of Antimicrobial Chemotherapy, 1989